Theseus Pharmaceuticals, Inc.
THRXDelisted Feb 14, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001745020
Theseus Pharmaceuticals, Inc. was delisted on Feb 14, 2024; its insiders filed their last Form 4 on Feb 14, 2024; 70 institutions reported holding it in 13F filings for Q4 2023, worth $145.8M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Theseus Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 51 | 51 | 0 |
| Shares | 34.7M | 34.6M | −60.7K (−0.2%) |
| Value | $191.6M | $200.7M | +$9.08M (+4.7%) |
New holders (2)
Institutions that held Theseus Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BNP Paribas Arbitrage, SA | 15,310 | $88.8K | 0.00% |
| Forefront Analytics, LLC | 13,065 | $74.0K | 0.04% |
Sold out (2)
Institutions that held Theseus Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 22,402 | $124.0K |
| D. E. Shaw & Co., Inc. | 10,412 | $58.0K |